Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia
© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association..
INTRODUCTION: Subjective cognitive decline (SCD) and depressive symptoms (DS) frequently co-occur prior to dementia. However, the temporal sequence of their emergence and their combined prognostic value for cognitive decline and dementia is unclear.
METHODS: Temporal relationships of SCD, DS and memory decline were examined by latent difference score modeling in a high-aged, population-based cohort (N = 3217) and validated using Cox-regression of dementia-conversion. In 334 cognitively unimpaired SCD-patients from memory-clinics, we examined the association of DS with cognitive decline and with cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers.
RESULTS: In the population-based cohort, SCD preceded DS. High DS were associated with increased risk of dementia conversion in individuals with SCD. In SCD-patients from memory-clinics, high DS were associated with greater cognitive decline. CSF Aß42 predicted increasing DS.
DISCUSSION: SCD typically precedes DS in the evolution to dementia. SCD-patients from memory-clinics with DS may constitute a high-risk group for cognitive decline.
HIGHLIGHTS: Subjective cognitive decline (SCD) precedes depressive symptoms (DS) as memory declines. Emerging or persistent DS after SCD reports predict dementia. In SCD patients, more amyloid pathology relates to increasing DS. SCD patients with DS are at high risk for symptomatic progression.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Alzheimer's & dementia : the journal of the Alzheimer's Association - 19(2023), 5 vom: 30. Mai, Seite 2056-2068 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kleineidam, Luca [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alzheimer's disease |
---|
Anmerkungen: |
Date Completed 15.05.2023 Date Revised 21.06.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/alz.12785 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM347333389 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM347333389 | ||
003 | DE-627 | ||
005 | 20231226033558.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/alz.12785 |2 doi | |
028 | 5 | 2 | |a pubmed24n1157.xml |
035 | |a (DE-627)NLM347333389 | ||
035 | |a (NLM)36218120 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kleineidam, Luca |e verfasserin |4 aut | |
245 | 1 | 0 | |a Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.05.2023 | ||
500 | |a Date Revised 21.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association. | ||
520 | |a INTRODUCTION: Subjective cognitive decline (SCD) and depressive symptoms (DS) frequently co-occur prior to dementia. However, the temporal sequence of their emergence and their combined prognostic value for cognitive decline and dementia is unclear | ||
520 | |a METHODS: Temporal relationships of SCD, DS and memory decline were examined by latent difference score modeling in a high-aged, population-based cohort (N = 3217) and validated using Cox-regression of dementia-conversion. In 334 cognitively unimpaired SCD-patients from memory-clinics, we examined the association of DS with cognitive decline and with cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers | ||
520 | |a RESULTS: In the population-based cohort, SCD preceded DS. High DS were associated with increased risk of dementia conversion in individuals with SCD. In SCD-patients from memory-clinics, high DS were associated with greater cognitive decline. CSF Aß42 predicted increasing DS | ||
520 | |a DISCUSSION: SCD typically precedes DS in the evolution to dementia. SCD-patients from memory-clinics with DS may constitute a high-risk group for cognitive decline | ||
520 | |a HIGHLIGHTS: Subjective cognitive decline (SCD) precedes depressive symptoms (DS) as memory declines. Emerging or persistent DS after SCD reports predict dementia. In SCD patients, more amyloid pathology relates to increasing DS. SCD patients with DS are at high risk for symptomatic progression | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Alzheimer's disease | |
650 | 4 | |a depression | |
650 | 4 | |a latent difference score model | |
650 | 4 | |a subjective cognitive decline | |
650 | 4 | |a temporal sequence | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Amyloid beta-Peptides |2 NLM | |
700 | 1 | |a Wagner, Michael |e verfasserin |4 aut | |
700 | 1 | |a Guski, Jannis |e verfasserin |4 aut | |
700 | 1 | |a Wolfsgruber, Steffen |e verfasserin |4 aut | |
700 | 1 | |a Miebach, Lisa |e verfasserin |4 aut | |
700 | 1 | |a Bickel, Horst |e verfasserin |4 aut | |
700 | 1 | |a König, Hans-Helmut |e verfasserin |4 aut | |
700 | 1 | |a Weyerer, Siegfried |e verfasserin |4 aut | |
700 | 1 | |a Lühmann, Dagmar |e verfasserin |4 aut | |
700 | 1 | |a Kaduszkiewicz, Hanna |e verfasserin |4 aut | |
700 | 1 | |a Luppa, Melanie |e verfasserin |4 aut | |
700 | 1 | |a Röhr, Susanne |e verfasserin |4 aut | |
700 | 1 | |a Pentzek, Michael |e verfasserin |4 aut | |
700 | 1 | |a Wiese, Birgitt |e verfasserin |4 aut | |
700 | 1 | |a Maier, Wolfgang |e verfasserin |4 aut | |
700 | 1 | |a Scherer, Martin |e verfasserin |4 aut | |
700 | 1 | |a Kornhuber, Johannes |e verfasserin |4 aut | |
700 | 1 | |a Peters, Oliver |e verfasserin |4 aut | |
700 | 1 | |a Frölich, Lutz |e verfasserin |4 aut | |
700 | 1 | |a Wiltfang, Jens |e verfasserin |4 aut | |
700 | 1 | |a Lewczuk, Piotr |e verfasserin |4 aut | |
700 | 1 | |a Hüll, Michael |e verfasserin |4 aut | |
700 | 1 | |a Ramirez, Alfredo |e verfasserin |4 aut | |
700 | 1 | |a Jessen, Frank |e verfasserin |4 aut | |
700 | 1 | |a Riedel-Heller, Steffi G |e verfasserin |4 aut | |
700 | 1 | |a Heser, Kathrin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Alzheimer's & dementia : the journal of the Alzheimer's Association |d 2005 |g 19(2023), 5 vom: 30. Mai, Seite 2056-2068 |w (DE-627)NLM168942356 |x 1552-5279 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2023 |g number:5 |g day:30 |g month:05 |g pages:2056-2068 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/alz.12785 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2023 |e 5 |b 30 |c 05 |h 2056-2068 |